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Abstract c-Cbl-associated protein (CAP), also called
Sorbs1 or ponsin, has been described as an essential
adapter protein in the insulin-signalling pathway. Here, we
describe for the first time a unique protective role for CAP
in viral myocarditis. Mortality and heart failure develop-
ment were increased in CAP-/- mice compared to CAP?/?
littermates after Coxsackievirus (CVB3) infection. Mech-
anistically, CAP protected from tissue apoptosis because of
reduced CD8? T and natural killer cell cytotoxicity.
Despite reduced cytotoxic elimination of CVB3-infected
cells in CAP?/? hearts, however, CAP enhanced interferon
regulatory factor 3 (IRF3)-dependent antiviral type I
interferon production and decreased viral proliferation
in vitro by binding to the cytoplasmic RIG-I-like receptor
melanoma differentiation-associated protein 5 (MDA5).
Taken together, these findings reveal a novel modulatory
role for CAP in the heart as a key protein stabilizing
antiviral type I interferon production, while protecting from
excessive cytotoxic responses. Our study will help to define
future strategies to develop treatments to limit detrimental
responses during viral heart inflammation.
Keywords Myocarditis  Heart failure  Inflammation 
Type I interferons  Perforin  Coxsackievirus
Introduction
c-Cbl-associated protein (CAP), also identified as Sorbs1
(Sorbin and SH3 domain-containing protein 1) or ponsin,
belongs to the SoHo vinexin family of adapter proteins.
Together with nectin and afadin, CAP composes the cell–
cell adhesion system named NAP [22]. CAP interacts with
several molecules, which modulate cell adhesion, cell
migration, cytoskeleton, membrane trafficking, and intra-
cellular signalling [17, 19, 47]. Remarkably, CAP has been
described to be an essential adapter protein in the insulin-
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signalling pathway forming a complex with Cbl and flo-
tillin, the latter being localized to the lipid raft of the cel-
lular plasma membrane [5]. Structurally, CAP is localized
with actin cytoskeleton, stress fibres, focal adhesion, cell–
cell adhesion structures, and has been also found in the
cellular nucleus [18, 29, 46].
c-Cbl-associated protein is mainly expressed in heart,
skeletal muscle, adipose tissue, and macrophages [19, 30].
Studies on a mouse model of high-fat diet-induced insulin
resistance recently suggested a pro-inflammatory role for
CAP. Accordingly, high-fat diet feeding increased pro-
inflammatory cytokine and chemokine release from mac-
rophages [19]. Despite the fact that a role of CAP in viral
infection has not been described yet, these observations
point toward a potential regulatory role of CAP in the
innate immune system.
Together with Toll-like receptors TLR3, TLR4, TLR7,
and TLR9, the PPR retinoic acid-induced gene I (RIG-I)-
like receptors (RLRs) melanoma differentiation-associated
protein 5 (MDA5) and RIG-I, identify virus particles and,
in addition to NF-jB nuclear translocation, induce TBK1/
IKKe-dependent activation of interferon regulatory factors
(IRFs) which results in the production of antiviral inter-
ferons (IFNs) [2, 16]. In particular, IRF3 plays a critical
role in IFN-b production, while IRF7 regulates both IFN-a
and IFN-b [15, 32].
The Coxsackie virus B3 (CVB3), a cardiotropic
positive single-strand RNA (?ssRNA) enterovirus, is an
important cause of myocarditis, which often progresses
to end-stage heart failure [31]. TLR3 and MDA5 rec-
ognize CVB3 double-strand RNA in the intracellular
endolysosome or directly in the cytosol, respectively [2,
16, 44]. Another RLR helicase, RIG-I, recognizes nega-
tive single-strand RNA (-ssRNA) viruses such as the
vesicular stomatitis virus (VSV) [16]. After infection,
TLR3/MDA5- or TLR3/RIG-I-triggered type I IFNs on
one side, and cytotoxic CD8? T cells and NK cells
eliminating virus-infected cells on the other side, limit
virus expansion in the host [3, 11]. In the presence of
severe infection, however, perforin-induced cytolysis
may trigger extensive pro-apoptotic signalling pathways
in heart tissue [3]. Extensive tissue damage together with
a strong systemic inflammatory response, on the other
hand, predisposes to heart-specific autoimmunity and
heart failure progression [9].
c-Cbl-associated protein has several functions and is
highly expressed in the heart. Since a role for CAP in
antiviral protection has not yet been elucidated, we
aimed to clarify whether CAP may influence antiviral
responses in cardiac diseases. To this end, we used a
mouse model of Coxsackievirus-induced myocarditis
to demonstrate the novel and beneficial dual role of
CAP.
Results
CAP protects from CVB3-induced myocarditis
To clarify the in vivo role of CAP in viral heart disease, we
infected CAP-/- mice and CAP?/? littermate controls with
CVB3 and analysed mortality, cardiac function, and myo-
carditis severity. In CAP?/? mice, CAP was constitutively
expressed at the RNA level before infection, decreased
until day 4 after infection, and raised again until day 7 post
infection (p.i.) (Fig. 1a). Survival curve showed enhanced
mortality in CAP-/- mice compared to CAP?/? littermate
controls in the first week of infection during acute myo-
carditis (Fig. 1b). Cross sections of H&E-stained infected
hearts showed higher disease scores in CAP-/- compared
to CAP?/? hearts at day 7 (Fig. 1c, left and right). Echo-
cardiography demonstrated impaired fractional shortening
in CVB3-infected CAP-/- mice compared to CAP?/?
controls at day 7 (Fig. 1d, Suppl. Fig. S1).
Despite the fact that overall disease scores did not differ
at day 4, flow cytometry showed higher percentages of
heart-infiltrating dendritic cells and macrophages in
infected CAP?/? hearts at this time point (Fig. 1e, Suppl.
Fig. S1b). In contrast, cytotoxic NK and CD8? T cells
among CD45high- and CD3?-expressing cardiac infiltrates,
respectively, were higher in CAP-/- mice compared to
CAP?/? mice (Fig. 1e, f, Suppl. Fig. S1b, c). CD4? T cells,
however, showed higher percentages in infected CAP?/?
hearts compared to CAP-/- hearts (Fig. 1f, Suppl. Fig.
S1c).
Taken together, these observations suggest that CAP
exerts a protective effect in CVB3-mediated viral myo-
carditis. Compared to CAP-/- hearts, CAP?/? hearts show
enhanced infiltrations with cells of myeloid origin, such as
dendritic cells and macrophages, but reduced cytotoxic
cells of lymphoid origin, such as CD8? T cells and NK
cells.
Enhanced lymphocyte activation in the absence of CAP
Levels of CD3? T cells, cytotoxic CD8? T cells, and
CD49b?CD3- NK cells showed only non-significant dif-
ferences in spleens of non-infected CAP?/? vs. CAP-/-
mice at baseline (Suppl. Fig. S2a, b). After CVB3 infec-
tion, however, percentages of CD8?CD44high T cells and
CD49b?CD3- NK cells became significantly higher in
spleens of CAP-/- mice compared to CAP?/? controls
(Fig. 2a, b, Suppl. Fig. S2c). In contrast, percentages of
effector CD4?CD44high T cells remained almost compa-
rable in both CAP?/? and CAP-/- spleens (Fig. 2a, Suppl.
Fig. S2c). Similarly, we found more heart-infiltrating
cytotoxic CD8 T and NK cells in CAP-/- compared to
CAP?/? mice after CVB3 infection (Fig. 1e, f).
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Lymphocytes activation and proliferation critically
involve T cell receptor (TCR) downstream molecules such
as the cytoplasmic signal transducer Lck and Zap-70 [38].
Phosphorylation of the Src family protein tyrosine kinase
Lck at the regulatory tyrosine Y192, which in turn induces
Zap-70 phosphorylation and amplifies TCR signal trans-
duction and cytokines production [48], was increased in
CAP-/- splenocytes (Fig. 2c).
Beside antiviral cytokines, Lck and the transmembrane
receptor CAR directly determine CVB3 infectivity [21]. We
therefore measured CAR and Lck in CVB3-infected hearts,
and found that their expression was CAP independent
(Suppl. Fig. S2d). To better characterise T cell activation
level, we measured the activation marker CD69. Consis-
tently, we observed higher CD69 expression in CAP-/-
than in CAP?/? T cells after in vitro stimulation (Fig. 2e).
CAP+/+
CAP-/-
B
Days after CVB3 infection
Su
rv
iva
l (%
)
CAP
GAPDH
Spleen
CAP+/+ CAP-/-
D0 D4 D0 D4D7 D7
CAP
GAPDH
Heart
CAP+/+ CAP-/-
D0 D4 D0 D4D7 D7
A
Fr
ac
tio
na
l s
ho
rte
ni
ng
 (%
)
D
CA
P+
/+
CA
P-
/-
CD3
SS
C
CD
8
CD4
F
Pa
th
ol
og
y 
sc
or
e
C CAP+/+
D
ay
 4
D
ay
 7
CAP-/-
SS
C
CA
P+
/+
CA
P-
/-
CD45
CD
11
b
E
8.1
±0.48
9.35
±0.74
10.1
±1.9
18.2
±3.21
32.8
±4.15
10.4
±3.16
1.01
±0.25
0.88
±0.18
LVESDLVEDD
CAP+/+
LVESDLVEDD
CAP-/-
CD11c
0102 103 104 105
0
102
103
104
105 14.2
±2.04
0102 103 104 105
0
102
103
104
105 9.62
±1.61
PD
CA
1
0102 103 104 105
0
102
103
104
105 13.5
±2.26
0102 103 104 105
0
102
103
104
105 6.46
±1.41
CD11b
F4
/8
0
0102 103 104 105
0
102
103
104
105 13.6
±1.79
0102 103 104 105
0
102
103
104
105 6.51
±1.85
Ly
6G
0102 103 104 105
0
102
103
104
105 6.24
±2.06
0102 103 104 105
0
102
103
104
105 4.96
±1.3
CD
49
b
0102 103 104 105
0
102
103
104
105 4.46
±1.06
0102 103 104 105
0
102
103
104
105 8.45
±2.01
CD3
Fig. 1 CAP protects from CVB3-induced myocarditis. a Quantitative
RT-PCR analysis of CAP RNA expression in hearts and spleens
before, 4, and 7 days after CVB3 challenge. b Survival rates of age-
and sex-matched CAP?/? (n = 20) and CAP-/- (n = 20) mice
injected with 5 9 10e4 pfu/mouse CVB3. Log-rank test,
*P = 0.0368. c Left—hematoxylin and eosin staining of CAP?/?
and CAP-/- heart cross sections. Right—pathological scores evalu-
ating heart-infiltrating cells from score 0 to score 4 according to the
range previously described [25]. Magnification 9200. d Cardiac
function of mice at the baseline before CVB3 infection and 7 days
after CVB3 infection was assessed by echocardiography (n = 7 each
group). Left ventricular diameters were determined by transthoracic
M-mode echocardiographic tracings. LV fractional shortening (FS)
was calculated using the formula FS = [(LVEDD - LVESD)/
LVEDD] 9 100. e Flow cytometry analysis of heart-infiltrating cells
of the innate immune system 4 days post infection. Triple staining of
CD45high-gated heart-infiltrating CD11c?CD11b? myeloid DC,
CD11c?PDCA1? plasmacytoid DC, CD11b?F480? monocytes/mac-
rophages, CD11b?Ly6G? granulocytes, CD49b?CD3- natural killer
(NK) cells. At least 200,000 events have been acquired from a live
gate. f Flow cytometry analysis of heart-infiltrating T cells 4 days
post infection. Triple staining of CD3?-gated heart-infiltrating CD4?
and CD8? T cells. At least 200,000 events have been acquired from a
live gate. Data are representative for two independent experiments (a,
c, e, f), n = 5 each group if not otherwise described (mean, SD).
*P \ 0.05, *P \ 0.01 (Student’s t test)
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Fig. 2 Limited activation of
cytotoxic lymphocytes in the
presence of CAP. a, b Flow
cytometry analysis of
CD3?CD4?CD44high and
CD3?CD8?CD44high effector T
cells (a) and CD3-CD49? NK
cells (b) in the spleen of
infected mice 4 days after
CVB3 challenge. c (Left)
Immunoblot analysis of p-Lck,
total Lck, total Zap-70, and
GAPDH in lysed splenocytes
suspensions before and 4 days
after CVB3 infection. (Right)
Ratio between the densitometric
evaluation of p-Lck and total
Lck, and the densitometric
evaluation of Zap-70 and
GAPDH. d Quantitative RT-
PCR analysis of cytolytic
perforin and granzyme B 4 days
after CVB3 infection in hearts
and spleens. e Expression of the
activation marker CD69 on
splenocytes suspensions
simulated in vitro with plate-
bound CD3/CD28 antibodies for
48 h. Analysis was performed
by flow cytometry. f, g
Intracellular flow cytometry
analysis of splenocytes
suspensions stimulated in vitro
with plate-bound CD3/CD28
antibodies for 48 h. Perforin
(f) and granzyme B
(g) production was detected in
cytotoxic CD3?CD8? T cells
and CD3-CD49b? NK cells.
Data are representative for two
independent experiments (e–g),
n = 5 each group (a–d) (mean,
SD). *P \ 0.05, *P \ 0.01
(Student’s t test)
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Interestingly, we measured comparable expression of
co-stimulatory molecules CD40, CD80, and CD86, as well
as MHCII, on antigen presenting CAP?/? and CAP-/-
cells after in vitro stimulation (Suppl. Fig. S3a, b).
Efficient CVB3 clearance despite reduced CD8 T
and NK cell responses in CAP?/? compared to CAP-/-
mice
CD8? T cell- and NK cell-induced cytotoxicity is largely
mediated by perforin, which lyse virus-infected cells and
eliminate the offending virus [11]. CAP inhibited expres-
sion and production of perforin in hearts and spleens after
CVB3 infection and after in vitro stimulation (Fig. 2d, f).
Like perforin, granzyme B was similarly increased in
hearts of CVB3-infected CAP-/- mice (Fig. 2d). Its
expression in CVB3-infected spleens and in vitro-stimu-
lated splenic cells, however, showed comparable levels
between CAP?/? and CAP-/- (Fig. 2d, g). In line with
increased cardiac infiltrations of CD8 T and NK cells in
CVB3-infected CAP-/- mice, both virus titers and viral
proliferation were reduced in hearts and spleens of CAP-/-
mice 4 days after infection (Fig. 3a, b). At day 10, how-
ever, plaque assays showed comparably low virus titers in
hearts and spleens of both CAP-/- and CAP?/? mice
(Fig. 3a).
Checking the typical cytokine expression patterns of
activated primary T and NK cells in vitro, we observed that
IL-17A, but not IFN-c, was higher in CAP-/- than in
CAP?/? splenic CD4? T cells, cytotoxic CD8? T, and NK
cells (Suppl. Fig. S4a). Beside its role in CD4? Th1 lineage
commitment, the transcription factor T-bet, as well as the
transcription factor Eomes, also critically regulates the
cytolytic effector mechanism of CD8? T cells and NK cells
[40]. In fact, we found significantly increased expression of
T-bet and Eomes in spleens of CAP-/- mice 4 days after
infection (Suppl. Fig. S4b, c). In addition, and in accor-
dance with higher IL-17A production in CAP-/- cells, the
Th17 transcription factor RORc was highly expressed in
CAP-/- mice (Suppl. Fig. S4b).
bFig. 3 CAP limits pro-apoptotic cytotoxic responses. a Plaque-
forming assay of heart and spleen lysates collected 4, 7, and 10 days
after CVB3 infection. b Semi-quantitative RT-PCR analysis of CVB3
(?)-strand RNA infection and CVB3 (-)-strand RNA replication in
CAP?/? and CAP-/- hearts and spleens before and 4 days after
CVB3 infection. c Immunoblot analysis of p-Bad, total Bad,
Cytochrome c, and GAPDH in heart tissue lysates 4 days after
CVB3 infection. d Semi-quantitative RT-PCR analysis of CVB3 (?)-
strand RNA infection and CVB3 (-)-strand RNA replication in
CAP?/? and CAP-/- mouse neonatal cardiac fibroblasts (MNF)
(2 9 105 cells) co-cultivated with CAP?/? or CAP-/- NK cells
(2 9 105 cells), E:T ratio 1:1, infected with 1 MOI CVB3 (?) or left
uninfected (-) for 24 h. GAPDH was used as internal loading control.
e Immunoblot analysis of Cytochrome c in MNF after co-cultivation
with NK cells, infected with 1 MOI CVB3 (?) or left uninfected (-)
for 24 h, as described in (d). Data are representative for two
independent experiments (a–c), n = 5 each group, or three indepen-
dent experiments (e, f) (mean, SD). *P \ 0.05 (Student’s t test)
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CAP protects from virus-induced apoptosis
In view of the markedly enhanced mortality and impaired
cardiac function in CAP-/- mice compared to CAP?/?
mice, we hypothesized that the increased cytotoxic
response in the absence of CAP might promote activation
of pro-apoptotic pathways in CAP-/- mice. To prove this
hypothesis, we measured major pro-apoptotic molecules
Bad and Cytochrome c in CVB3-infected hearts. Bad is
inactive in its phosphorylated form, but when de-phos-
phorylated, contributes to Cytochrome c release from the
mitochondria activating several caspases, which ultimately
mediate apoptosis [8]. As expected, CAP-/- hearts showed
lower levels of inactive, phosphorylated Bad (Fig. 3c).
Consistently, CAP-/- hearts expressed higher amounts of
Cytochrome c compared to CAP?/? hearts (Fig. 3c). To
test if enhanced apoptotic signals in CAP-/- mice were
directly mediated through cytotoxic cells, we co-cultivated
mouse neonatal cardiac fibroblasts (MNF) and NK cells
in vitro. As observed in Fig. 3d and e, CAP-/- NK cells
strongly inhibited viral proliferation on one side, but also
promoted high levels of pro-apoptotic Cytochrome c
release on the other side. It is know that the activation of
the PI3K/Akt pathway modulates apoptosis. However, we
excluded that the PI3K/Akt pathway determined apoptosis
in the absence of CAP, since CVB3-infected mice did not
show any difference between CAP?/? and CAP-/- in
phosphorylated PI3K and Akt in spleens and hearts (Suppl.
Fig. S5a, b).
CAP promotes type I IFNs production in vivo
So far, we provided evidence that CAP protects from virus-
triggered tissue damage and cytotoxicity in CVB3-medi-
ated myocarditis. Efficient clearance of infective agents,
however, had proven critical for host survival in the long
term. We therefore asked how the CVB3-infected organism
controls viral load while reducing the cytotoxic effect of
CD8 T and NK cells. Given the importance of interferons
during early antiviral defence, we therefore addressed
whether and how CAP regulates type I and II IFNs.
Accordingly, we measured RNA expression levels of type I
and II IFNs, IRF3, and IRF7 in CAP?/? and CAP-/- after
CVB3 infection. RNA expression of all type I IFNs tested,
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Fig. 4 CAP promotes type I IFNs production in vivo. a, b Quanti-
tative RT-PCR analysis of RNA expression of antiviral type I (IFN-
a1, IFN-a4, and IFN-b) and type II (IFN-c) IFNs in the heart 4 and
10 days after CVB3 infection (a) and in the spleen at day 4 post
CVB3 infection (b). c Quantitative RT-PCR analysis of RNA
expression of the two major type I IFNs transcription regulators,
namely IRF3 and IRF7, in hearts and spleens 4 days post CVB3
infection. d Concentration of IFN-b proteins measured by ELISA in
blood serum collected from mice 4 days after CVB3 infection.
e Immunoblotting analysis of MDA5, p-IRF3, and IRF3 in heart
lysates before and 4 days after CVB3 infection. Densitometry values
normalized to GAPDH are shown on the right. Data are representative
for two independent experiments, n = 5 each group (mean, SD).
*P \ 0.05, **P \ 0.01, ***P \ 0.001 (Student’s t test)
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namely IFN-a1, IFN-a4, and IFN-b, was higher in CAP?/?
hearts at day 4 p.i, and partially at day 10 p.i. compared to
CAP-/- hearts, while IFN-c did not differ (Fig. 4a). Sim-
ilarly, IFN-a1 and IFN-b, but not IFN-a4 and IFN-c, were
expressed at higher levels in CAP?/? spleens compared to
CAP-/- spleens at day 4 p.i. (Fig. 4b). Enhanced RNA
levels of the major type I IFNs transcription factors IRF3
and IRF7 in CAP?/? hearts and spleens at day 4 post-
CVB3 infection confirmed these results (Fig. 4c). To test if
CAP may influence type I IFN-dependent antiviral pro-
tection at the protein level, we collected blood serum from
CVB3-infected mice at day 4. Consistent with the RNA
expression data, analysis by ELISA showed that CAP?/?
mice produced higher levels of IFN-b than CAP-/- mice
(Fig. 4d). In addition, phosphorylation of IRF3, which
indicates IRF3 nuclear translocation and promotion of type
I IFNs transcription, was increased in CAP?/? hearts at day
4 post infection, while CAP-/- hearts showed only mini-
mal IRF3 phosphorylation (Fig. 4e).
MDA5, a cytosolic receptor recognizing CVB3 double-
strained RNA and triggering IRF3 phosphorylation [43], is
usually cleaved and degraded by CVB3 to limit type I IFN-
dependent host defence [4, 42]. We observed that CAP
prevented MDA5 from degradation at the protein level in
the heart after CVB3 infection (Fig. 4e).
Taken together, CAP promotes type I IFN-dependent
antiviral protection in acute CVB3-induced myocarditis.
CAP supports type I IFN-dependent antiviral protection
in vitro
To test how CAP promotes type I IFNs production in vitro,
we next stimulated MEF, BMDC, and BMM with ligands
for TLR3 (PolyIC), TLR7 (R848), MDA5, and RIG-I and
measured IFN-b and IFN-a1 induction. Since MDA5 and
RIG-I are cytosolic RLRs helicases, we induced activation
of MDA5 and RIG-I by transfecting cells with HMW-
PolyIC and LMW-PolyIC, respectively [27]. ELISA was
used to analyse IFN-b at the protein level in supernatants,
while IFN-b and IFN-a1 RNA levels were measured by
qRT-PCR. We found that TRL3 and TLR7 ligands, as well
as RIG-I, induced comparable amounts of IFN-b in both
CAP?/? and CAP-/- cells (Fig. 5a), while MDA5 ligand
induced higher levels of IFN-b in CAP?/? cells than in
their CAP-/- counterparts (Fig. 5b, c). Similar to stimu-
lation with HMW-PolyIC, which mimics viral (?)RNA
ligands for MDA5, infection with CVB3 led to signifi-
cantly higher levels of IFN-b in CAP?/? BMDM compared
to CAP-/- BMDC, while VSV infection, similar to LMW-
PolyIC, which mimics viral (-)RNA ligands for RIG-I,
showed comparable IFN-b production in both cells
(Fig. 5d, e). IFN-a1 levels were differently over-expressed
in CAP?/? and CAP-/- cells. Upon HMW-PolyIC
stimulation, IFN-a1 and IFN-b RNA levels were higher in
CAP?/? BMDC. CAP?/? and CAP-/- MEF, however,
showed comparable IFN-a1 expression (Fig. 5c, d). Simi-
larly, comparable IFN-a1 over-expression was observed in
CAP?/? and CAP-/- BMDC and MEF after CVB3 or VSV
infection (Fig. 5f, g).
To figure out how CAP promotes type I IFNs produc-
tion, we infected MEF with CVB3 and measured MDA5
and IRF3 protein expression. Indeed, MDA5 activation led
to IRF3 phosphorylation and type I IFNs production [1]. As
shown in Fig. 5h, MDA5 was properly expressed in the
presence of CAP, while the absence of CAP was associated
with a constant reduction of MDA5. Consequently, IRF3
phosphorylation was normal in infected CAP?/? MEF, but
not in their CAP-/- counterparts (Fig 5h). These findings
suggest that CAP is necessary for proper signalling trans-
duction for type I IFNs production.
HeLa cells are suitable to study the function of CAP,
since this cell line does not express endogenous CAP [47].
To figure out whether CAP reduces susceptibility to virus
infections, we transfected HeLa cells with either a CAP-
expressing vector or a mock vector as control. Transfected
HeLa cells were then CVB3 infected and direct plaque
assays were performed. As expected, CAP-transfected, but
not mock-transfected HeLa cells, showed reduced viral
proliferation (Fig. 5i, left). Similarly, MEF were infected
with CVB3 for 24 h and cell lysates were used to test viral
proliferation by plaque assay. Similar to transfected HeLa
cells, CVB3-infected CAP?/? MEF showed lower viral
proliferation compared to CAP-/- MEF (Fig. 5i, right).
Since CAP is highly expressed in the heart [19, 46], we
next addressed the role of CAP in mouse cardiac cells.
Consequently, we measured the expression of type I and
type II IFNs by real-time quantitative RT-PCR after
infecting mouse neonatal cardiac fibroblasts (MNF) with
CVB3. Both CAP?/? and CAP-/- cells expressed com-
parable high levels of IFN-b and IFN-c, but IFN-a1
expression was significantly higher in CAP?/? MNF
compared to CAP-/- MNF (Fig. 5j). These results suggest
that increased IFN-a1 and IFN-b expression observed in
CAP?/? hearts 4 days after CVB3 infection (Fig. 4a)
reflects enhanced production of IFN-a1 by cardiac cells on
one side, and IFN-b production by heart-infiltrating den-
dritic cells and macrophages on the other side.
To figure out if increased IFN-a1 expression in CAP?/?
cardiac cells promotes antiviral protection, mouse neonatal
cardiomyocytes (MNC) and MNF were infected in vitro
with CVB3. Viral entry and viral proliferation were mea-
sured by reverse transcription of CVB3 genomic (?)RNA
strand and (-)RNA strand sequences, respectively, which
are then analysed by semi-quantitative RT-PCR [20].
CVB3 entry into cells is confirmed by the detection of the
(?)RNA strand. The CVB3 (-)RNA strand, on the other
Basic Res Cardiol (2014) 109:411 Page 7 of 14
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hand, reflects the presence of viral replication intermedi-
ates, corresponding to viral proliferation [20]. As shown in
Fig. 5k, both CVB3 (?)RNA and (-)RNA strands were
reduced in CAP?/? MNC (Fig. 5k, top row) and MNF
(Fig. 5k, bottom row) compared to their CAP-/- counter-
parts as early as 24 h after infection. Thus, CAP reduces
CVB3 entry into cells as well as CVB3 replication.
Mechanistically, the antiviral effect of CAP results from its
role as a positive regulator of type I IFNs expression.
CAP supports MDA5 expression, while blocking
MyD88
So far, we showed that CAP promotes type I IFN expres-
sion by enhanced phosphorylation of IRF3. However, the
interaction between CAP and signalling molecules down-
stream of TLRs or RLRs receptors has not been investi-
gated yet. To this end, we transfected HeLa cells with a
CAP-encoding vector and infected them with CVB3.
Immunoblotting of total cell lysates confirmed higher
MDA5 expression before and after CVB3 infection in
CAP-transfected cells compared to mock-transfected cells
(Fig. 6a). IRF3, MyD88, and p65 as well as general protein
poly- and monoubiquitination were similar (Fig. 6a). To
analyse molecular interactions at different time points we
immunoprecipitated FLAG-tagged CAP proteins. Looking
at the most relevant proteins involved in CVB3-mediated
type I IFNs production, we observed that MDA5 was the
only molecule of the antiviral pathway, which interacted
with CAP (Fig. 6b). Our observations were confirmed by
co-immunoprecipitation of MDA5 with CAP-FLAG
(Fig. 6c). Since relevant portions of the CAP protein,
namely the SH3 sorbin domains, are needed to complex to
the plasma membrane [5], we evaluated MDA5 expression
in HeLa cells transfected with FLAG-tagged CAP-wt or a
FLAG-tagged CAP plasmid lacking of its SH3 domains
(CAP-DSH3). Immunoprecipitation of FLAG-tagged CAP
showed that the SH3 domains are necessary for CAP to
complex with MDA5, but total cell lysates analysis con-
firmed that MDA5 expression was not dependent on SH3
domains of CAP (Fig. 6d). Thus, CAP contributes to
proper MDA5 expression.
In addition, we found that MyD88 was the only mole-
cule of the NF-jB pathway, which complexed with CAP
before CVB3 infection (Fig. 6b). Since MyD88 ubiquiti-
nation induces MyD88 degradation, which then down-
regulates the pro-inflammatory MyD88-dependent NF-jB
pathway [24], we immunoprecipitated MyD88 and mea-
sured its ubiquitination. As hypothesized, MyD88 was
ubiquitinated at a higher extent in CAP-transfected HeLa
cells compared to mock-transfected HeLa cells after CVB3
infection (Fig. 6e).
Taken together, our data suggest that binding of CAP to
MyD88 results in ubiquitination and degradation of this
adaptor molecule and consequently inhibition of the
MyD88-dependent pro-inflammatory pathway.
Discussion
In the present study, we provide for the first time evidence
for a regulatory role of CAP in innate antiviral immunity.
In fact, we found a dual role of CAP in promoting antiviral
type I IFNs production, while reducing cytotoxic respon-
ses. Moreover, we recognized that CAP is part of the
MDA5 complex that specifically recognizes (?)ssRNA
viruses, such as the myocarditis-inducing CVB3, but not
(-)ssRNA viruses.
To fight viral infections, the host activates several
immune mechanisms to limit viral proliferation. Fast and
prompt migration of lymphoid cells of myeloid origin, such
as dendritic cells and macrophages, are critical for initial
viral clearance. These cells produce IRF3-, IRF5-, and
IRF7-dependent antiviral IFNs after identifying genomic
particles of invading RNA viruses [15, 32, 42]. We have
recently described the protective role of early heart-infil-
trating monocytes/macrophages expressing the chemokine
receptor CCR5 within 2 days after CVB3 infection [42]. In
bFig. 5 CAP contributes to MDA5-dependent, but not TLR3/TLR7-
dependent, production of type I IFNs. a, b IFN-b production in CAP?/
? (black bars) and CAP-/- (white bars) MEF, BMDM, and BMM
was measured in cell-free supernatants by ELISA after 24 h
stimulation with 10 ng/ml PolyIC, 2.5 lg/ml R848, or left untreated
(a) or 24 h after transfection with 1 ng/ml HMW-PolyIC, 1 ng/ml
LMW-PolyIC, or mock (b). c Same BMDC (c) and MEF (d) as in (b),
but harvested 6 h after transfection; IFN-b and IFN-a1 RNA levels
were measured by qRT-PCR. e CVB3 at 1 MOI or VSV at 1 MOI
were used for direct in vitro infection of BMDC. IFN-b was measured
in cell-free supernatants by ELISA 24 h after infection. f, g BMDC
(f) and MEF (g) were infected with 1 MOI CVB3 or 1 MOI VSV for
6 h; IFN-b and IFN-a1 RNA levels were measured by qRT-PCR.
h MEF from CAP?/? and CAP-/- mice were infected with 1 MOI
CVB3 for the indicated times. Immunoblot analysis of cell lysates
performed with antibodies detecting MDA5, phosphorylated IRF-3,
and total IRF-3. The arrow points at the band indicating phosphor-
ylated IRF3. UT untreated. UN uninfected. n.d. not detected. i (Left)
Plaque assay directly performed on HeLa cells transfected with CAP-
encoding plasmid or mock-plasmid infected with CVB3 for 1 h and
incubated in agar solution for 48 h. (Right) Cell lysates from CAP?/?
and CAP-/- MEF infected for 48 h with CVB3 were used for plaque
assay in HeLa cells. j Gene expression of IFN-a1, IFN-b, and IFN-c
in mouse neonatal cardiac fibroblasts 12 h after infection with 1 MOI
CVB3, analysed by qRT-PCR. k Mouse neonatal cardiomyocytes
(top) and mouse neonatal cardiac fibroblasts (bottom) infected with
CVB3 at 1 MOI for the indicated times. Semi-quantitative RT-PCR
performed with 1 lg RNA reverse transcribed with (?) strand CVB3
primers, (-) strand CVB3 primers, or random primers. GAPDH was
reverse transcribed with random primers and used as internal control.
Data are representative for three experiments performed in triplicates
(mean, SD). *P \ 0.05 (Student’s t test)
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parallel, host defence builds up CD8? T and NK cell-
mediated responses to eliminate virus-infected cells. CD8?
T and NK cells produce pore-forming perforin and gran-
zymes that ultimately induce apoptosis of virus-infected
cells [11]. Type I IFNs and cytotoxic proteins induce dif-
ferent antiviral responses. Indeed, type I IFNs, by binding
to their receptors on the surface of dendritic cells and
macrophages, promote the expression of IFN-stimulated
genes (ISGs), such as Protein kinase R (PKR), 2050-oli-
goadenylate synthetase (OAS), Mx, viperin, and many
others [28]. Co-ordinated activation of different ISGs can
efficiently inhibit viral proliferation by blocking cell cycle
of virus-infected cells, by preventing transport of incoming
viral nucleocapsids into the cell nucleus, by interacting
with viral capsids rendering virions non-infectious, or by
inducing apoptosis of infected cells [28, 35]. Therefore,
apoptosis induction in virus-infected cells is only one of
several type I IFNs-mediated antiviral mechanisms pro-
tecting the host. Perforin and granzymes are necessary for
proper viral clearance, but at the same time they induce the
activation of apoptotic processes. The entry of perforin and
granzymes into target cells is a pivotal step for initiating
apoptosis leading to death of target cardiac cells [23].
Granzymes, and in particular granzyme B, induce cell
apoptosis by activating Bid, dephosphorylating Bad, and
promoting the release of Cytochrome c from the mito-
chondria, which ultimately results in caspase-dependent
cell death [6, 39]. Perforin mediates cardiomyocyte injury
in acute myocarditis caused by CVB3 [34]. It is also known
that perforin induces higher mortality and increased myo-
carditis severity in CVB3-infected mice [10, 12]. CD8 T
cells worsen myocarditis scores but reduce myocardial
viral titers [13]. Our results therefore suggest that CAP?/?
mice, which develop a strong type I IFN-dependent anti-
viral response and dampen cytotoxic cells, are subjected to
less cardiac tissue injury than CAP-/- mice, which pref-
erentially mount strong cytotoxic antiviral responses.
Although CAP-/- hearts and spleens showed reduced viral
proliferation at day 4 post CVB3 infection, we conclude
that enhanced cytotoxicity renders CAP-/- mice more
susceptible to CVB3-induced mortality during the first
week after CVB3 inoculation.
Several studies describe perforin-producing lympho-
cytes in hearts of patients with viral myocarditis and in the
hearts of CVB3-infected mice [33, 34, 45]. In addition,
blockade of perforin with anti-perforin neutralizing anti-
bodies limits cardiac cell injury in mice with viral myo-
carditis [12]. In our study, we observed increased
expression of both perforin and granzyme B in hearts of
CAP-/- CVB3-infected mice compared to CAP?/? CVB3-
infected controls. Interestingly, perforin was higher in
spleens of CAP-/- compared to CAP?/? CVB3-infected
mice, while granzyme B showed comparable expression.
At this time point, we cannot explain this observation, but a
growing body of evidence points to granzyme B-indepen-
dent, perforin-mediated cytotoxic mechanisms [14, 37].
Nevertheless, CAP reduces perforin-mediated cell apop-
tosis in the CVB3-infected heart.
In the present study, we found that CAP was necessary
to induce IFN-b production upon MDA5 stimulation, but
not upon TLR3, TLR7, and RIG-I activation. Indeed,
MDA5, a cytosolic helicase with specificity toward posi-
tive double-strand RNA viruses [16], is one of the preferred
targets of invading viruses. RNA viruses escape cellular
antiviral responses by cleaving and degrading MDA5,
thereby reducing type I IFNs production and increasing
myocarditis susceptibility [4, 43]. Here, we found that CAP
prevented MDA5 from CVB3-induced degradation. In
addition, when CAP was expressed in HeLa cells, which
are otherwise unable to produce CAP [47], MDA5 com-
plexed with CAP after viral infection. We therefore con-
clude that CAP acts as a stabilizing molecule for MDA5,
which in turn enhances antiviral responses against CVB3.
Interestingly, in our pulling-down experiments, we
observed that CAP complexed with MyD88, but not with
other downstream proteins of the MyD88-IRAKs-TRAFs
axis. Impaired or depleted MyD88 function results in
general reduction of pro-inflammatory cytokine expression
upon TLR activation except of TLR3 [1]. Nevertheless,
future studies are needed to understand how exactly CAP-
dependent modulation of MyD88 influences inflammatory
cytokine expression.
Aside from antiviral mechanism, invading viruses can
take advantage of the cellular structure of the host.
Interaction with host transmembrane receptors in the
heart, such as CAR and DAF, promotes conformational
changes in the capsid of CVB3 that are essential for viral
entry and release of viral RNA [7]. Intracellular signals
triggered by both receptors include tyrosine kinase Lck,
which is used by CVB3 to rearrange host cytoskeleton and
thus increase viral entry [21]. Of note, Lck, apart from
being target of CVB3, is well-known tyrosine kinase that
promotes ZAP-70 recruitment for T cell receptor down-
stream signalling that activates T cells [38]. In the present
study, we observed that CAP neither modified CAR nor
Lck expression in the heart, but reduced Lck phosphory-
lation in splenocytes. By measuring the expression of
CD69 and CD44high, we confirmed that CAP?/? T cells
were less activated and had lower memory/effector
capacity than CAP-/- T cells. While reducing migration
of cytotoxic CD8? T and NK cells, CAP also inhibited
perforin and granzyme B production after viral infection
in vivo and in vitro. Furthermore, transcription factors
Eomes and T-bet, which are related to cytotoxicity [11,
40], were highly expressed in CAP-/- but not in CAP?/?
spleen.
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Taken together, we demonstrated for the first time a
novel function of CAP as immune modulator in virus-
induced cardiac inflammation. Our data show that CAP
exerts a broad range of protective effects against
(?)ssRNA virus infection, balancing immune responses
towards a favourable outcome. CAP supports type I IFNs
while reducing detrimental cytotoxic signals. Modulating
CAP production might be a potential therapeutic strategy in
acute viral myocarditis in the future, in particular to pre-
vent end-stage heart failure.
Materials and methods
Mice, cells, viruses, and plasmids
Six- to eight-week-old CAP-/- male C57BL/6 mice (also
known as Sorbs1-/- mice) were previously described [19].
All animal experiments were conducted in accordance with
the Animal Care Committee of the University Health
Network of the University of Toronto. Mouse embryonic
fibroblasts (MEF) were cultivated using embryos at day
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Fig. 6 CAP complexes with MDA5 and MyD88. a HeLa cells were
transfected with CAP-wt-FLAG plasmid and then infected with 1
MOI CVB3 for the indicated times. Whole cell lysates (WCL) were
immunoblotted with the indicated antibodies. b CAP-wt-FLAG-
transfected HeLa cell lysates were immunoprecipitated with anti-
FLAG antibodies and immunoblotted with the indicated antibodies
(top). WCL were immunoblotted with the same antibodies (below).
c HeLa cells were transfected with CAP-wt-FLAG plasmid and then
infected with 1 MOI CVB3 for the indicated times. Cell lysates were
immunoprecipitated with anti-MDA5 or anti-MyD88 antibodies and
then immunoblotted with the indicated antibodies. d HeLa cells were
transfected with CAP-wt-FLAG or CAP-DSH3-FLAG plasmid and
then infected with 1 MOI CVB3 for the indicated times. FLAG
immunoprecipitates of WCL were immunoblotted with the indicated
antibodies. e CAP-wt-FLAG- or mock-transfected HeLa cells were
immunoprecipitated with MyD88 and then immunoblotted with
antibodies detecting polyubiquitin. Data are representative for two
to three independent experiments
Basic Res Cardiol (2014) 109:411 Page 11 of 14
123
13.5 of gestation. Bone marrow-derived macrophages
(BMM) and bone marrow-derived dendritic cells (BMDC)
were cultivated as previously described [9, 41]. Mouse
neonatal cardiomyocytes (MNC) were cultivated from the
ventricles of 1-day-old newborns, digested with tripsin
(0.8 mg/ml) and plated for 2 h at 37 C to separate mouse
neonatal cardiac fibroblasts (MNF) from MNC, and then
cultivated in the presence of BrdU. The cardiovirulent
CVB3 (Gauntt strain) has been described previously [20,
36], the vesicular stomatitis virus (VSV) was a gift of Dr.
J. Bell. Viral titration in HeLa cells by standard plaque
assay was performed as previously described [20, 36].
FLAG-tagged plasmids encoding CAP and CAP-DSH3
were a kind gift of Dr. Alan Saltiel [5, 47].
Histology
Cross sections of mouse hearts were hematoxylin and eosin
stained as described [26], and evaluated for cellular infil-
trates and necrosis as follows: 0, absence of infiltrating
cells or necrosis; 1, limited focal areas of infiltrating cells
or necrosis; 2, mild to moderate infiltrating cells or
necrosis; 3, moderate infiltrating cells or necrosis; 4,
extensive areas with infiltrating cells or necrosis involving
the entire examined heart tissue.
Isolation of heart-infiltrating cells and flow cytometry
analysis
Hearts were digested using Liberase TM Research Grade
(Roche Diagnostics) at a working concentration of 0.08
Wuensch U/ml for 45 min at 37 C. Heart-infiltrating cells
were always triple-stained and first gated on live CD45high
lymphocytes plotted on side-scatter/CD45high cells,
acquired with a BD LSR II or a BD FACSCanto II (BD
Biosciences), and analysed with FlowJo (Tree Star). Data
were acquired until 200,000 events were collected from a
live gate, as previously described [41].
Quantitative RT-PCR (qRT-PCR) and semi-
quantitative RT-PCR
RNA was isolated with Trizol Reagent (Invitrogen)
according to the manufacturer’s protocol. Reverse tran-
scription was performed with 1 lg RNA. The 2-DDCt
method was used for qRT-PCR gene expression analysis.
To reverse transcribe the CVB3 (?)RNA strand, we used
the following primer: 50-CACCGGATGGCCAATCCA-30.
To amplify its cDNA, we used the following primers for
semi-quantitative RT-PCR:
(forward) 50-CTCTCAATTGTCACCATAAGCAGCCA-30;
(reverse) 50-GCGAAGAGTCTATTGAGCTA-30, as
previously described [20].
Elisa
Commercially available VeriKine ELISA kit (PBL Inter-
feron Source) was used to measure IFN-b.
Western blot analysis and immunoprecipitation
Tissue or cell lysates were separated using NuPAGE No-
vex Bis–Tris gel (Invitrogen), transferred on PVDF mem-
brane (Roche Diagnostic), and then immunoblotted with
specific antibodies. Bands were visualized with an ECL
chemiluminescent substrate (Luminata Crescendo, Milli-
pore). For immunoprecipitation, Dynabeads Protein G
(Invitrogen) were used according to the manufacturer’s
instructions. FLAG-tagged proteins were immunoprecipi-
tated using anti-DDK Tag (L5) Affinity Gel (Biolegend).
Reagents
High molecular weight (HMW) polyinosinic–polycytidylic
acid (polyIC), low molecular weight (LMW) PolyIC, and
the imidazoquinoline R848 were purchased from Invivo-
gen. LPS and CpGs were purchased from Sigma.
Histopathology
Cross sections of paraffin-embedded hearts cut at 5 lm were
stained with hematoxylin and eosin to evaluate inflammatory
infiltrates reflecting myocarditis scores graded from 0 to 4 [25].
Echocardiography
Transthoracic 2D, M-mode, and Doppler echocardiographic
studies were performed with an Acuson Sequoia C256 sys-
tem equipped with a 15-MHz linear transducer (15L8)
(Version 4.0, Acuson Corp) in mice anaesthetized with
isoflurane/oxygen (1/100 %). M-mode tracings were recor-
ded through these anterior and posterior LV walls at the
papillary muscle level to measure LV end-diastolic dimen-
sion (LVEDD) and LV end-systolic dimension (LVESD).
LV fractional shortening (FS) was calculated using the for-
mula FS = [(LVEDD - LVESD)/LVEDD] 9 100.
Statistics
Survival rates were analysed by the Kaplan–Meier method,
and differences between groups were tested with the log-
rank test. Normally distributed data were compared using
the unpaired two-tailed Student t test. Statistical analysis
was conducted using the Prism 5 software (GraphPad
Software). All data were expressed as mean ± SD. Dif-
ferences were considered statistically significant for
P \ 0.05.
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